Xiangxue Pharmaceutical Capital Reinvestment Ratio
Xiangxue Pharmaceutical capital reinvestment ratio. Xiangxue Pharmaceutical (300147) has a Capital Reinvestment Ratio of 0.08x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥75.64 Million) in capital expenditures (CN¥5.74 Million). Check Xiangxue Pharmaceutical investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Xiangxue Pharmaceutical (2007–2025)
Capital reinvestment ratio of Xiangxue Pharmaceutical from 2007 to 2025. This chart tracks Xiangxue Pharmaceutical's Capital Reinvestment Ratio across 19 annual periods. Also explore Xiangxue Pharmaceutical annual equity growth to track the company's year-over-year net asset growth rate.
Xiangxue Pharmaceutical Capital Reinvestment Ratio by Year (2007–2025)
Xiangxue Pharmaceutical capital reinvestment ratio by year from 2007 to 2025. For the full cash flow conversion analysis, see 300147 cash generation efficiency.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.15x | CN¥139.63 Million | CN¥21.51 Million | ▼ -92.1% |
| 2024 | 1.94x | CN¥18.17 Million | CN¥35.24 Million | ▲ +811.6% |
| 2023 | 0.21x | CN¥263.44 Million | CN¥56.03 Million | ▼ -86.8% |
| 2022 | 1.62x | CN¥227.38 Million | CN¥367.27 Million | ▼ -26.1% |
| 2021 | 2.18x | CN¥257.56 Million | CN¥562.74 Million | ▼ -20.6% |
| 2020 | 2.75x | CN¥257.18 Million | CN¥707.42 Million | ▼ -65.5% |
| 2019 | 7.96x | CN¥83.02 Million | CN¥661.09 Million | ▲ +46.6% |
| 2018 | 5.43x | CN¥91.24 Million | CN¥495.46 Million | ▼ -23.5% |
| 2017 | 7.10x | CN¥109.53 Million | CN¥777.87 Million | ▼ -28.3% |
| 2016 | 9.91x | CN¥198.48 Million | CN¥1.97 Billion | ▲ +471.9% |
| 2015 | 1.73x | CN¥159.89 Million | CN¥276.95 Million | ▲ +17.6% |
| 2014 | 1.47x | CN¥165.58 Million | CN¥243.85 Million | ▲ +51.8% |
| 2013 | 0.97x | CN¥328.37 Million | CN¥318.55 Million | ▼ -72.4% |
| 2012 | 3.52x | CN¥118.91 Million | CN¥418.12 Million | ▼ -55.0% |
| 2011 | 7.81x | CN¥29.55 Million | CN¥230.69 Million | ▲ +524.1% |
| 2010 | 1.25x | CN¥45.47 Million | CN¥56.87 Million | ▲ +9.3% |
| 2009 | 1.14x | CN¥46.19 Million | CN¥52.86 Million | ▼ -53.7% |
| 2008 | 2.47x | CN¥55.72 Million | CN¥137.71 Million | ▲ +135.7% |
| 2007 | 1.05x | CN¥138.02 Million | CN¥144.73 Million | — |